CYAD

Celyad Oncology SA American Depositary Shares
CYAD

Delisted

CYAD was delisted on the 18th of May, 2023.

Back to rankings

8 hedge funds and large institutions have $16.8M invested in Celyad Oncology SA American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$35K
2
+$1.17K

Top Sellers

1
-$65K
2
-$44K
3
-$9.7K
4
TRCT
Tower Research Capital (TRC)
New York
-$4K
5
HF
HRT Financial
New York
-$3.12K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$15.8M
2
$777K
3
$88K
4
$49K
5
$42K
6
$35K
7
$10K
8
$8K
9
–
10
–
11
–